Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News vTv Therapeutics Inc VTVT

Healthcare Biotechnology
vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VTVT)

vTv Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire February 13, 2026

vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737

GlobeNewswire February 2, 2026

vTv Therapeutics and M42's IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health

GlobeNewswire December 18, 2025

vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire November 6, 2025

vTv Therapeutics Announces New Appointments to its Scientific Advisory Board

GlobeNewswire October 9, 2025

vTv Therapeutics Will Participate in INNODIA Symposium at the EASD 61st Annual Meeting

GlobeNewswire September 15, 2025

UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences

GlobeNewswire September 3, 2025

vTv Therapeutics to Participate in Upcoming September Investor Conferences

GlobeNewswire September 3, 2025

vTv Therapeutics Announces $80 Million Private Placement with Leading Healthcare Institutional Investors and the T1D Fund

GlobeNewswire September 2, 2025
View More News ››

Opinion & Analysis (NDAQ:VTVT)

vTv Therapeutics' Shares open 80% Higher on Phase 2 Type 1 Diabetes Trial Data

Streetwise Reports February 11, 2020
View More Opinion ››

Bullboard Posts (NDAQ:VTVT)

still holding this stock

for over a year,there was big buying by insiders all of last year,and this is a long term hold for me, which is about a year in my terms...
coolfooldumbguy - February 10, 2020

still holding this stock

it is starting to pick up.so glta.
coolfooldumbguy - January 2, 2019

coming year should be good for me

with this stock bought it last week,so glta.
coolfooldumbguy - December 31, 2018

RE:bought this morning at

A few months back I bought it at $1.92 just before they announced their Phase 3 failed. Sold it at $1.22 and bought CRMD at 58 cents...
Pandora - December 28, 2018

bought this morning at

$2.15 per share,should do really well with it in the coming year,was on my watchlist for a time, but today was the day for buying it,so...
coolfooldumbguy - December 28, 2018

RE:RE:RE:Jump on

should be halted here soon I would think
billybob22 - October 3, 2018
View more Bullboard ››

Nuclear Vision Ltd.

Nuclear Vision Ltd.

Nuclear Vision Limited operates as a uranium exploration company. Its material property is the Regnault Project that consists ...
View More »

Podcasts